Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

The COVID-19 pandemic has caused significant economic disruptions, with the stock market dropping about 20% and unemployment soaring.

That’s according to WalletHub, which ranked states across 10 key metrics, looking at the share of employment by small businesses, the share of GDP from highly affected industries in a state, and unemployment claims.

While Louisiana was the most exposed state overall, Rhode Island actually saw the highest increase in the number of initial unemployment insurance claims, at 4,574.93% in the 12th week of 2020 compared to the same time period in 2019. Utah, which had the lowest increase in unemployment insurance claims, saw a 50.52% increase.

Here are the top 10 states with most exposed economies:

  • Louisiana
  • Rhode Island
  • Nevada
  • Maine
  • New Hampshire
  • Pennsylvania
  • Montana
  • New Jersey
  • Massachusetts
  • Illinois

Mississippi, Louisiana, Alabama, West Virginia and Arkansas had the lowest share of workers working from home. Several states and businesses have shifted to working from home to keep people from congregating at office buildings and spreading the virus.

Here are the states with the least exposed economies

  • Arkansas
  • Nebraska
  • Alabama
  • South Dakota
  • Utah
  • Oregon
  • Alaska
  • California
  • Georgia

See the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.